Related Experiment Video
Updated: Oct 29, 2025

08:12
Synthesis and Operation of Fluorescent-core Microcavities for Refractometric Sensing
Published on: March 13, 2013
13.0K
Femtomolar Biodetection by a Compact Core-Shell 3D Chiral Metamaterial
Mariachiara Manoccio1,2, Marco Esposito1, Elisabetta Primiceri1
1CNR NANOTEC Institute of Nanotechnology, Via Monteroni, 73100 Lecce, Italy.
Nano Letters
|July 12, 2021
Summary
This study introduces a novel chip-based metamaterial sensor for early disease diagnostics. It detects extremely low biomarker concentrations, enabling advanced disease progression monitoring for neurodegenerative conditions.
Area of Science:
- Nanotechnology
- Biomedical Engineering
- Optical Sensing
Background:
- Advanced sensing tools are crucial for early disease diagnostics and monitoring.
- Detecting extremely low concentrations of circulating biomarkers remains a challenge.
Purpose of the Study:
- To demonstrate the sensing capabilities of a chip-based metamaterial with a functional core-shell nanoarchitecture.
- To achieve highly sensitive detection of biomarkers for neurodegenerative diseases.
Main Methods:
- Fabrication of a chip-based metamaterial with 3D chiral geometry and a functional core-shell nanoarchitecture.
- Utilizing the metamaterial's circular polarization-dependent optical response for analysis.
- Conformal coating with a polymer shell to enhance biomolecule interaction.
Main Results:
- The chiral metamaterial exhibited a circular polarization-dependent optical response, minimizing background interference.
- The functional nanoarchitecture enhanced biomolecule interaction through energy transfer mechanisms.
- Achieved a system sensitivity slope of 27 nm/pM for detecting TAR DNA-binding protein 43.
- Detected biomarker concentrations from 1 pM down to 10 fM in spiked solutions and human serum.
Conclusions:
- The developed metamaterial sensor offers a new route for early diagnostics and disease progression monitoring.
- The system's high sensitivity and broad detection range surpass conventional immunological assays.
- Opens new perspectives for next-generation biomedical sensing systems.

